Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2023-08-09 00:00:00 ET · period of report 2023-08-07 · accession 0001439222-23-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-09 | 2023-08-07 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | S - Sale | $25.39 | -2,918 | 2,741 | -52% | -$74.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-08-07 | S | D | 2,918 | $25.39 | 2,741 | D | — | — | (F1) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.22 to $25.40. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |